Literature DB >> 8625069

Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients.

I O Ng1, E C Lai, S T Fan, M M Ng, M K So.   

Abstract

BACKGROUND: In patients with hepatocellular carcinoma, surgical resection may offer a chance of cure. However, tumor recurrence is not infrequent after resection.
METHODS: To identify the pathologic factors that are of prognostic significance and predictive value in tumor recurrence, the authors studied 278 patients (243 men, 35 women) who had hepatectomy for hepatocellular carcinoma. Disease free and actuarial survival were correlated with 20 pathologic parameters of the resected specimens using multivariate analysis.
RESULTS: The median follow-up period was 23.6 months. The overall disease free survival rates at 1, 3 and 5 years were 42%, 23%, and 17%, respectively, and the overall actuarial survival rates for the corresponding time periods were 70%, 39%, and 28%, respectively. The results indicated that tumor encapsulation (P = 0.004) and heavy intratumor inflammatory infiltrates (P = 0.003) were independent favorable factors related to tumor recurrence. Negative resection margins (P = 0.001) and heavy intratumor inflammatory infiltrates (P = 0.003) were independent favorable factors correlated with survival.
CONCLUSIONS: From this analysis, it was determined that detailed histologic examination of resected specimens of hepatocellular carcinoma is important in assessing long term prognosis and stratification of patients for treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8625069     DOI: 10.1002/1097-0142(19951215)76:12<2443::aid-cncr2820761207>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

2.  Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.

Authors:  Minghui Wu; Hongna Tan; Fei Gao; Jinjin Hai; Peigang Ning; Jian Chen; Shaocheng Zhu; Meiyun Wang; Shewei Dou; Dapeng Shi
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

3.  Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy.

Authors:  Siu Tim Cheung; Jenny C Y Ho; Ka Ling Leung; Xin Chen; Daniel Y T Fong; Samuel So; Sheung Tat Fan
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

4.  Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.

Authors:  Weihua Guo; Suhong Zhao; Yuhai Yang; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center.

Authors:  Jie Wang; Lei-Bo Xu; Chao Liu; Hao-Wei Pang; Ya-Jin Chen; Qing-Jia Ou
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

6.  Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study.

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Po-Chuan Wang; Shou-Chuan Shih; Wen-Hsing Chang; Horng-Yuan Wang; Chung-Chu Chen; Li-Rung Shyung
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma.

Authors:  Jenny C Y Ho; Siu Tim Cheung; Wing Sem Poon; Yuk Ting Lee; Irene O L Ng; Sheung Tat Fan
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-12       Impact factor: 4.553

8.  Surgical management of hepatocellular carcinoma: resection or transplantation?

Authors:  B Philosophe; P D Greig; A W Hemming; M S Cattral; I Wanless; I Rasul; N Baxter; B R Taylor; B Langer
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

9.  Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy.

Authors:  Wei-Chen Lee; Ming-Chin Yu; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

10.  Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Authors:  Ke Hao; John M Luk; Nikki P Y Lee; Mao Mao; Chunsheng Zhang; Mark D Ferguson; John Lamb; Hongyue Dai; Irene O Ng; Pak C Sham; Ronnie T P Poon
Journal:  BMC Cancer       Date:  2009-11-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.